Genmab drug becomes more accessible in the US

Tepezza, which Genmab developed under the ownership of Horizon Therapeutics, has now entered the portfolio of products offered through the largest group of independent specialty pharmacies in the US.
Photo: Jon Cherry/AFP / GETTY IMAGES NORTH AMERICA
Photo: Jon Cherry/AFP / GETTY IMAGES NORTH AMERICA
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN

Premier Pharmacy Services has now incorporated the Genmab-developed drug Tepezza in its product assortment, according to a press release from the pharmacy chain.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading